| Literature DB >> 32093322 |
Maria Fiorella Mazzeo1, Diomira Luongo1, Toshihiro Sashihara2, Mauro Rossi1, Rosa Anna Siciliano1.
Abstract
Probiotics play a key role in the modulation of the gut immune system in health and disease and their action is mediated by molecules exposed on the microorganism surface or secreted probiotic-derived factors. In particular, Lactobacillus gasseri OLL2809, a probiotic microorganism isolated from human feces, has the potential to modulate various immune responses. The dendritic cells (DCs) are considered the main players in orchestrating the immune response, and their contact with intestinal microbiota is crucial for the development and homeostasis of gut immunity. To gain a perspective on the molecular mechanisms involved in the maturation process of DCs and investigate factors that could modulate these processes, a differential proteomic analysis was performed on the secretome of immature DCs, mature DCs (mDCs, induced by lipopolysaccharide (LPS)), and immature DCs challenged with L. gasseri OLL2809 before treatment with LPS (LGmDCs). The maturation process of DCs was associated to profound changes in the protein secretome and probiotic pre-treatment led to a dramatic modulation of several secreted proteins of mDC, not only classical immune mediators (i.e., cytokines, complement factors, T cell Receptor ligands) but also proteins involved in the contractile and desmosome machineries. The latter data highlight a novel mechanism by which L. gasseri can modulate the maturation process of DCs, reinforcing the concept of a protective anti-inflammatory role ascribed to this probiotic strain.Entities:
Keywords: Lactobacillus gasseri; dendritic cells; immunomodulation; mass spectrometry; probiotics; proteomics; secreted proteins
Mesh:
Substances:
Year: 2020 PMID: 32093322 PMCID: PMC7071482 DOI: 10.3390/nu12020555
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Phenotype of dendritic cells (DCs) cultured in X-Vivo 15 medium and challenged with L. gasseri. Immature dendritic cells (iDCs) were challenged or not with irradiated L. gasseri and then subjected to a 6-h lipopolysaccharide (LPS) pulse to induce DC maturation. (A) Fluorescence-activated cell sorting (FACS) analysis of DCs double-stained for CD80 and CD86; light grey line, iDCs; dark grey line, mDCs; dotted line, L. gasseri OLL2809 challenged iDCs (LGmDCs). (B) Cytokine analysis (Interleukin-10 (IL-10) and Interleukin-12 (IL-12))of iDCs, mature dendritic cells (mDCs), and LGmDCs. Data were collected from ungated cells and are representative of three independent experiments. *** p < 0.01 (ANOVA test).
Figure 2Protein–protein interaction network of proteins identified in the secretome of immature DCs. The Gene Name according to UniProtKB are reported. The network was obtained using the EMBL STRING with a confidence cut-off of 0.700 [24]. The four main functional modules are circled and numbered.
Figure 3Bar diagram summarizing the functional classification of proteins present in the mDCs secretome (blue bars) and in the secretome of iDCs (green bars) achieved by Reactome Pathway Database analysis.
Results of the differential proteomic study: proteins whose abundance was affected by the maturation process of DCs challenged or not with L. gasseri and functional classification obtained by the Reactome Pathway Database.
| ACCESSION | DESCRIPTION | GENE NAME | FUNCTIONAL CLASSIFICATION | FOLD CHANGE | |
|---|---|---|---|---|---|
| mDCs/iDCs | LGmDCs/mDCs | ||||
|
| |||||
| Q542G9 | Annexin 2 | Anxa2 | Innate Immune System | 32.54 | |
| P01027 | Complement C3 | C3 | Innate Immune System | 12.29 | −16.16 |
| Q3U6A3 | Monocyte differentiation antigen CD14 | Cd14 | Innate Immune System | 8.91 | |
| Q3UD32 | Uncharacterized protein | Ctss | Innate Immune System | −2.42 | |
| Q9ES94 | Cathepsin Z | Ctsz | Innate Immune System | 1.97 | 1.53a |
| E9Q557 | Desmoplakin | Dsp | Innate Immune System | 14.13 | −5.86 |
| Q3UBK2 | Uncharacterized protein | Hmgb1 | Innate Immune System | −3.80 | 3.85 |
| Q02257 | Junction plakoglobin | Jup | Innate Immune System | 8.07 | −5.13 |
| P08905 | Lysozyme C-2 | Lyz2 | Innate Immune System | −2.97 | |
| Q3TFQ8 | Alpha-1,4 glucan phosphorylase | Pygb | Innate Immune System | 25.10 | −4.13 |
| Q4FJQ0 | MCG130610 | Rab7 | Innate Immune System | 3.80 | −3.52 |
| Q60842 | Chromosome 24p3 (Fragment) | Lcn2 | Innate Immune System | 18.34 | −24.10 |
| Q5FWA0 | Ribonuclease T2B | Rnaset2b | Innate Immune System | 17.80 | −6.96 |
| B8JJN0 | Uncharacterized protein | Cfb | Innate Immune System | 10.86 | |
| P43432 | Interleukin-12 subunit beta | Il12b | Cytokine Signaling in Immune System | 19.36 | 1.89a |
| P25085 | Interleukin-1 receptor antagonist protein | Il1rn | Cytokine Signaling in Immune System | 3.65 | |
| P29391 | Ferritin light chain 1 | Ftl1 |
| 3.63 | −2.28 |
| P01921 | H-2 class II histocompatibility antigen, A-D beta chain | H2-Ab1 |
| 22.45 | |
| P06343 | H-2 class II histocompatibility antigen, A-K beta chain | H2-Ab1 |
| 8.33 | |
|
| |||||
| Q64426 | Histone H2A (Fragment) | Hist2h2aa1 | Signaling by Nuclear Receptors | 12.83 | |
| Q6P8R3 | C-X-C motif chemokine | Pf4 | Signaling by GPCR | 5.72 | −1.98a |
| Q3US43 | Annexin 1 | Anxa1 | Signaling by GPCR | 61.76 | −22.14 |
| P60766 | Cell division control protein 42 homolog | Cdc42 | Signaling by Rho GTPases | -2.88 | |
| Q3THE2 | Myosin regulatory light chain 12B | Myl12b | Signaling by Rho GTPases / | 3.80 | |
|
| |||||
| Q91VH3 | Tpm2 protein | Tmp2 | Striated Muscle Contraction | 4.71 | −2.20 |
| F8WID5 | Tropomyosin alpha-1 chain | Tpm1 | Striated Muscle Contraction | 3.55 | |
| B2RQQ1 | MCG133649, isoform CRA_a | Myh6 | Striated Muscle Contraction | 13.33 | −9.83 |
| B2RWW8 | Myosin, heavy polypeptide 8 | Myh8 | Striated Muscle Contraction | 35.12 | −25.91 |
| B2RWX0 | Myosin, heavy polypeptide 1 | Myh1 | Striated Muscle Contraction | 37.49 | −27.66 |
| B1AR69 | Myosin, heavy polypeptide 13 | Myh13 | Striated Muscle Contraction | 11.44 | −8.44 |
| Q5SX39 | Myosin-4 | Myh4 | Striated Muscle Contraction | 37.62 | −27.75 |
|
| |||||
| Q8BTM8 | Filamin-A | Flna | Platelet activation, signaling, and aggregation | 14.59 | −18.85 |
| P11276 | Fibronectin | Fn1 | Platelet activation, signaling, and aggregation | −74.75 | |
| Q9WVA4 | Transgelin-2 | Tagln2 | Platelet activation, signaling, and aggregation | 2.30 | |
|
| |||||
| P34960 | Macrophage metalloelastase | Mmp12 | Degradation of extracellular matrix | −1.80a | 4.47 |
| P24369 | Peptidyl-prolyl cis-trans isomerase B | Ppib | Collagen Formation | 3.44 | |
|
| |||||
| H3BKH6 | S-formylglutathione hydrolase | Esd | Biological Oxidations | 2.08 | |
| P08226 | Apolipoprotein E | Apoe | Metabolism of vitamins and cofactors | −3.64 | |
| Q9WUB3 | Glycogen phosphorylase | Pygm | Metabolism of carbohydrate | 51.35 | −10.93 |
| P63242 | Eukaryotic translation initiation factor 5A-1 | Eif5a | Metabolism of proteins | 13.51 | |
| A2AB79 | Histone H2A | Hist3h2a | Metabolism of proteins | 11.72 | |
|
| |||||
| Q3U1N0 | Coronin | Coro1a | 2.52 | ||
| Q20BD0 | Heterogeneous nuclear ribonucleoprotein A/B, isoform CRA_a | Hnrnpa | 7.24 | ||
| P04918 | Serum amyloid A-3 protein | Saa3 | 14.27 | ||
| Q99LB4 | Capping protein (Actin filament), gelsolin-like, isoform CRA_a | Capg | −2.33 | 1.84a | |
| B9EIU3 | Attractin | Atrn | −2.10 | 2.61 | |
a proteins with fold change values in the range ± 1.5–2.0.
Figure 4Bar diagram summarizing the most relevant results of the quantitative proteomic analyses and reporting the natural logarithm (Ln) of fold change values obtained comparing mDCs vs. iDCs and LGmDCs vs. mDCs. Fold change values are reported in Table 1. Positive values of Ln (fold change) indicate an increase in protein amount, while negative values of Ln (fold change) indicate a decrease in protein amount. (A) Proteins mainly involved in the immune response. (B) Proteins mainly involved in contractile machinery. These proteins showed a significant increase in fold changes when comparing mDCs vs. iDCs (blue bars) and a dramatic decrease when comparing LGmDCs vs. mDCs (red bars).